Lista de obras - Simon Tiberi - Dominio Público Uruguay

A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany, May 2016

scholarly article by SO Brockmann et al published 12 April 2018 in Eurosurveillance

A strange case of waitress headache

artículo científico publicado en 2011

Accelerating the development of therapeutic strategies for drug-resistant tuberculosis.

artículo científico publicado en 2018

An increase of infective endocarditis cases in England seen with concomitant reduction in antibiotic prophylaxis since the implementation of NICE guidelines in 2008: possible explanations

artículo científico publicado en 2015

Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.

artículo científico publicado en 2016

Back pain, leg swelling and a cardiac arrest: an interesting case of endocarditis

artículo científico publicado en 2014

Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!

artículo científico publicado en 2018

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2017

Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis

artículo científico publicado en 2016

Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use

scientific article published on 29 August 2013

Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

artículo científico publicado en 2015

Breast tuberculosis in East London: A 13-year retrospective observational study

scientific article published on 04 September 2019

Bronchopleural fistula, tuberculous empyema and bilateral lung destruction treated in various stages by medical and surgical intervention

Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study

artículo científico publicado en 2018

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

artículo científico publicado en 2016

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

artículo científico publicado en 2017

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

artículo científico publicado en 2016

Challenging MDR-TB clinical problems - The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs.

artículo científico publicado en 2019

Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives

artículo científico publicado en 2016

Classifying new anti-tuberculosis drugs: rationale and future perspectives

artículo científico publicado en 2016

Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.

artículo científico publicado en 2018

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

artículo científico publicado en 2017

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

artículo científico publicado en 2018

Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis

artículo científico publicado en 2018

Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic

artículo científico publicado en 2020

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

artículo científico publicado en 2016

Defining the best regimen to treat isoniazid-resistant tuberculosis.

artículo científico publicado en 2018

Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review

artículo científico publicado en 2017

Differential diagnosis of a palmar and plantar rash

artículo científico publicado en 2013

Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing

article

ERS/ECDC Statement: European Union Standards for Tuberculosis Care - 2017 update.

artículo científico publicado en 2018

ERS/WHO tuberculosis consilium: reporting of the initial 10 cases

artículo científico publicado en 2013

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2016

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

artículo científico publicado en 2017

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

artículo científico publicado en 2016

Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

artículo científico publicado en 2012

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for

scientific article published on 25 June 2020

Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.

artículo científico publicado en 2015

Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir

artículo científico publicado en 2005

Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis

artículo científico publicado en 2016

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

artículo científico publicado en 2016

Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?

artículo científico publicado en 2016

Giant thoracic aorta aneurysm causing airway and esophagus stenosis

artículo científico publicado en 2012

HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy.

artículo científico publicado en 2008

Imaging features and diagnosis of tuberculosis of the breast.

artículo científico publicado en 2017

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers

artículo científico publicado en 2016

Intestinal tuberculosis: a diagnostic challenge

artículo científico publicado en 2017

Inverse psoriasis

artículo científico publicado en 2015

Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?

artículo científico publicado en 2016

Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.

artículo científico publicado en 2018

Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study.

artículo científico publicado en 2015

Management and outcomes of severe childhood tuberculosis in the pediatric intensive care setting: can we identify best practices?

scientific article published on 25 April 2019

Management of patients with multidrug-resistant tuberculosis

artículo científico publicado en 2019

Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation

scientific article published on 25 April 2019

Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment

scientific article published on 01 December 2019

Multidrug-resistant tuberculosis in Europe, 2010-2011

artículo científico publicado en 2015

Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases

artículo científico publicado en 2018

Necrotizing pneumonia (aetiology, clinical features and management)

artículo científico publicado en 2019

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.

artículo científico publicado en 2018

New drugs and perspectives for new anti-tuberculosis regimens

artículo científico publicado en 2018

Non-tuberculous mycobacterial pulmonary disease: a clinical update

scientific article published on 01 August 2018

Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs

article

On Tuberculosis and COVID-19 co-infection

scientific article published on 25 June 2020

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery

artículo científico publicado en 2018

Post-implementation blues: the unfulfilled potential of Xpert

artículo científico publicado en 2017

Protecting ourselves from tuberculosis. Describing a historic poster printed in italy on 1937.

artículo científico publicado en 2014

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study

article

Regimen design and pharmacokinetic-pharmacodynamic science: lessons learned

scientific article published on 23 November 2018

Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis.

artículo científico publicado en 2018

Rifabutin: Is it useful in the treatment of multidrug-resistant tuberculosis?

artículo científico publicado en 2017

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

artículo científico publicado en 2017

Shigellosis and toxic megacolon secondary to Shigella flexneri serotype 3a: The challenges of laboratory diagnosis.

artículo científico publicado en 2018

Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis

artículo científico publicado en 2017

Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.

artículo científico publicado en 2018

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

scientific article published on 03 April 2019

Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 — “Wanted: Leaders for a TB-Free World. You can make history. End TB”

artículo científico publicado en 2018

Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond

artículo científico publicado en 2017

The Need for Global Regulation of Antibiotics: The Case of a Generic Oral Penem.

artículo científico publicado en 2016

The challenge of the new tuberculosis drugs

artículo científico publicado en 2017

The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control.

artículo científico publicado en 2018

The cursed duet today: Tuberculosis and HIV-coinfection

artículo científico publicado en 2017

Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians.

artículo científico publicado en 2016

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

artículo científico publicado en 2016

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

scientific article published in The Lancet

Treatment outcomes of MDR-TB and HIV co-infection in Europe

artículo científico publicado en 2017

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.

artículo científico publicado en 2017

Tuberculosis a disease that created and shaped thoracic surgery

artículo científico publicado en 2014

Tuberculosis a re-emerging disease

artículo científico publicado en 2012

Tuberculosis elimination, patients' lives and rational use of new drugs: revisited.

artículo científico publicado en 2015

Tuberculosis elimination: where are we now?

artículo científico publicado en 2018

Tuberculosis in the time of COVID-19: quality of life and digital innovation

artículo científico publicado en 2020

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.

artículo científico publicado en 2018

Videomediastinoscopy: a ten year experience on lung cancer stadiation and non-diagnosed mediastinal lymphoadenopathy

artículo científico publicado en 2014

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial

artículo científico publicado en 2010

WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.

artículo científico publicado en 2016

WHO recommendations on shorter treatment of multidrug-resistant tuberculosis

artículo científico publicado en 2016

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series

artículo científico publicado en 2019

Lista de obras de Simon Tiberi

A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany, May 2016

A strange case of waitress headache

Accelerating the development of therapeutic strategies for drug-resistant tuberculosis.

An increase of infective endocarditis cases in England seen with concomitant reduction in antibiotic prophylaxis since the implementation of NICE guidelines in 2008: possible explanations

Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.

Back pain, leg swelling and a cardiac arrest: an interesting case of endocarditis

Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis

Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use

Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

Breast tuberculosis in East London: A 13-year retrospective observational study

Bronchopleural fistula, tuberculous empyema and bilateral lung destruction treated in various stages by medical and surgical intervention

Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

Challenging MDR-TB clinical problems - The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs.

Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives

Classifying new anti-tuberculosis drugs: rationale and future perspectives

Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis

Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Defining the best regimen to treat isoniazid-resistant tuberculosis.

Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review

Differential diagnosis of a palmar and plantar rash

Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing

ERS/ECDC Statement: European Union Standards for Tuberculosis Care - 2017 update.

ERS/WHO tuberculosis consilium: reporting of the initial 10 cases

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for

Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.

Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir

Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?

Giant thoracic aorta aneurysm causing airway and esophagus stenosis

HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy.

Imaging features and diagnosis of tuberculosis of the breast.

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers

Intestinal tuberculosis: a diagnostic challenge

Inverse psoriasis

Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?

Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.

Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study.

Management and outcomes of severe childhood tuberculosis in the pediatric intensive care setting: can we identify best practices?

Management of patients with multidrug-resistant tuberculosis

Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation

Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment

Multidrug-resistant tuberculosis in Europe, 2010-2011

Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases

Necrotizing pneumonia (aetiology, clinical features and management)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.

New drugs and perspectives for new anti-tuberculosis regimens

Non-tuberculous mycobacterial pulmonary disease: a clinical update

Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs

On Tuberculosis and COVID-19 co-infection

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery

Post-implementation blues: the unfulfilled potential of Xpert

Protecting ourselves from tuberculosis. Describing a historic poster printed in italy on 1937.

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study

Regimen design and pharmacokinetic-pharmacodynamic science: lessons learned

Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis.

Rifabutin: Is it useful in the treatment of multidrug-resistant tuberculosis?

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

Shigellosis and toxic megacolon secondary to Shigella flexneri serotype 3a: The challenges of laboratory diagnosis.

Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis

Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 — “Wanted: Leaders for a TB-Free World. You can make history. End TB”

Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond

The Need for Global Regulation of Antibiotics: The Case of a Generic Oral Penem.

The challenge of the new tuberculosis drugs